Gonadotropin-releasing hormone analogs in ovulation induction: Current status and perspectives

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2413-2416

  Filicori, Marco ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Reproductive Endocrinology Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADORELIN DERIVATIVE; DRUG DERIVATIVE; GONADORELIN; LUTEINIZING HORMONE;

CONCEPTION; FEMALE; FEMALE INFERTILITY; GONADOTROPIN RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; OVULATION; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; METHODOLOGY; PERIODICITY; SECRETION;

FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION INDUCTION; PERIODICITY;

EID: 0030191987     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2413     Document Type: Review

References (23)

1. Filicori M, Flamigni C. 1988 GnRH agonists and antagonists. Current clinical status. Drugs. 35:63-82.
2. Filicori M, Flamigni C, Meriggiola MC, et al. 1991 Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives. Fertil Steril. 56:1-13.
3. Martin KA, Hall JE, Adams JM, Crowley WF. 1993 Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 77:125-129.
4. Filicori M, Flamigni C, Dellai P, et al. 1994 Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab. 79:1215-1220.
5. Filicori M, Campaniello E, Michelacci L, et al. 1988 Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. J Clin Endocrinol Metab. 66:327-333.
6. Gerhard I, Matthes J, Runnebaum B. 1993 The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive. Hum Reprod. 8:2033-2038.
7. Surrey ES, deZiegler D, Lu JKH, Chang RJ, Judd HL. 1989 Effects of gonadotropin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease. Fertil Steril. 52:547-552.
8. Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J. 1993 Pulsatile gonadotrophin releasing hormone Stimulation after medium-term pituitary suppression in polycystic ovary syndrome. Hum Reprod. 8(Suppl 2):197-199.
9. Filicori M, Flamigni C, Campaniello E, et al. 1989 The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management. J Clin Endocrinol Metab. 69:825-831.
10. Blumenfeld Z, Lang N, Amit A, Kahana L, Yoffe N. 1994 Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction. Fertil Steril. 62:456-460.
11. Tulchinsky D, Nash H, Brown K, Paoletti Falcone V, Polcaro J. 1991 A pilot study of the use of gonadotropin-releasing hormone analog for triggering ovulation. Fertil Steril. 55:644-646.
12. Dodson WC, Hughes CL, Whitesides DB, Haney AF. 1987 The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab. 65:95-100.
13. Jacobson A, Galen D, Milani H, Weckstein L, Jacobson J. 1991 A novel superovulation regimen: three-day gonadotropin-releasing hormone agonist with overlapping gonadotropins. Fertil Steril. 56:1169-1172.
14. Pantos K, Meimeth Damianaki T, Vaxevanoglou T, Kapetanakis E. 1994 Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program. Fertil Steril. 61:709-713.
15. Tan SL, Kingsland C, Campbell S, et al. 1992 The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril. 57:810-814.
16. Filicori M, Flamigni C, Cognigni GE, et al. 1996 Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril. 65:387-393.
17. Filicori M, Flamigni C, Cognigni G, et al. 1993 Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. J Clin Endocrinol Metab. 77:130-133.
18. Kang IS, Kuehl TJ, Siler-Khodr TM. 1989 Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon. Fertil Steril. 52:846-853.
19. Wilshire GB, Emmi AM, Gagliardi CC, Weiss G. 1993 Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril. 60:980-983.
20. Elefant E, Biour B, Blumberg Tick J, Roux C, Thomas F. 1995 Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline, Fertil Steril. 63:1111-1113.
21. Skarin G, Nillius SJ, Wide L. 1982 Failure to induce early abortion by huge doses of a superactive LRH agonist in women. Contraception. 26:457-463.
22. Dubourdieu S, Charbonnel B, D'Acremont MF, Carreau S, Spitz IM, Bouchard P. 1994 Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. J Clin Endocrinol Metab. 78:343-347.
23. Olivennes F, Fanchin R, Bouchard P, et al. 1994 The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril. 62:468-476.